{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:40:04Z","timestamp":1749318004062,"version":"3.41.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1097\/01.npr.0000753872.27819.f7","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:11:53Z","timestamp":1623949913000},"page":"10-13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Consequences of AV blockade omission in flecainide therapy"],"prefix":"10.1097","volume":"46","author":[{"given":"Jennifer A.","family":"Ferrante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammel","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Sakaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Eick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Tate","family":"Cutshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"7","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2019.12.041","article-title":"Use of Flecainide for the Treatment of Atrial Fibrillation","volume":"125","author":"Echt","year":"2020","journal-title":"Am J Cardiol"},{"issue":"23","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"38","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"issue":"24","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2165\/00003495-200464240-00003","article-title":"Pharmacological cardioversion of atrial fibrillation: current management and treatment options","volume":"64","author":"Boriani","year":"2004","journal-title":"Drugs"},{"issue":"2","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7326\/0003-4819-117-2-141","article-title":"Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter","volume":"117","author":"Falk","year":"1992","journal-title":"Ann Intern Med"},{"issue":"11","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/europace\/euv462","article-title":"Flecainide\u2013metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation","volume":"18","author":"Capucci","year":"2016","journal-title":"Europace"},{"issue":"4","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11599950-000000000-00000","article-title":"Safety of flecainide","volume":"35","author":"Tamargo","year":"2012","journal-title":"Drug Saf"},{"issue":"2","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v7.i2.76","article-title":"Flecainide: Current status and perspectives in arrhythmia management","volume":"7","author":"Andrikopoulos","year":"2015","journal-title":"World J Cardiol"},{"issue":"18","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of Diagnosed Atrial Fibrillation in Adults","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"R12-20250607","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/europace\/euq382","article-title":"Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation","volume":"13","author":"Aliot","year":"2011","journal-title":"Europace"},{"issue":"11","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"R14-20250607","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/STROKEAHA.109.571174","article-title":"Systematic Review and Pooled Analysis of Published and Unpublished Validations of the ABCD and ABCD2 Transient Ischemic Attack Risk Scores","volume":"41","author":"Giles","year":"2010","journal-title":"Stroke"},{"issue":"1","key":"R15-20250607","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0002-8703(54)90284-7","article-title":"Atrial flutter: 1 to 1 conduction during treatment with quinidine and digitalis","volume":"48","author":"London","year":"1954","journal-title":"Am Heart J"},{"issue":"17","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0002-9149(88)90282-2","article-title":"Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment","volume":"62","author":"Crijns","year":"1988","journal-title":"Am J Cardiol"},{"issue":"23","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \u201cpill-in-the-pocket\u201d approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"R18-20250607","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000119694","article-title":"Paranoid psychosis and myoclonus: flecainide toxicity in renal failure","volume":"111","author":"Ting","year":"2008","journal-title":"Cardiology"},{"issue":"1","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/HPC.0000000000000096","article-title":"Confused and Too Long","volume":"16","author":"Tsai","year":"2017","journal-title":"Crit Pathw Cardiol"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000753872.27819.f7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T17:02:04Z","timestamp":1749315724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000753872.27819.f7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000753872.27819.f7","relation":{},"ISSN":["0361-1817"],"issn-type":[{"type":"print","value":"0361-1817"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}